2021 annual financial data
Outlook Therapeutics 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -51.73M USD and net income was -53.16M USD.
Operating cash flow was Not available.
Get free Outlook Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -51.73M USD
- Net income
- -53.16M USD
- Operating cash flow
- Not available